Us Proton Therapy Market Opportunity Analysis

Dec 5th, 2014, Mumbai, India: Bharat Book Bureau presents the report, on “US Proton Therapy Market Opportunity Analysis”. The market for proton therapy centers and the demand for these facilities are growing driven by the number of cancer diagnoses. Of this prostate cancer that has about 186,320 patient additions a year has seen a favorable impression of the therapy.

Proton beam therapy is seen as the next great leap forward in treating cancer with radiation. It has been found that proton therapy is beneficial for tumors surrounded by sensitive structures such as the eye, brain, and spinal cord, where the organs are sensitive and there is high potential for radiation damage. Proton therapy is also very useful in childhood cancer treatment due to the high risk of long-term side effects in children during standard radiation treatment. The major advantage is that there is minimal or no side effects compared to conventional forms of radiation which makes this therapy much more easily tolerated than standard radiation therapy.

Proton therapy is applied to a specific area of the patient's body which means that this therapy can be used to shrink tumors that have not spread to other parts of the body. Tumors adjoining sensitive and critically important tissues such as the optic nerves that travel between the eye and brain need protection from radiation damage and such cases are best treated with proton therapy. Doctors now use proton therapy exclusively or in conjunction with standard radiation therapy, surgery, and/or chemotherapy. In children that are infected with cancer, proton therapy is particularly useful for treatment because it reduces the chance of harming healthy, developing tissue. Proton therapy can also be used in children for rare cancers of the central nervous system (brain and spinal cord) and the eye, such as retinoblastoma and orbital rhabdomyosarcoma.

In US, there are 14 proton therapy centers catering to a potential patient base of more than...